Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Am J Transplant. 2014 Jun 16;14(7):1630–1637. doi: 10.1111/ajt.12735

Table 5.

Recipient Outcomes

Total Conventional LDN

N=51		 LESS-DN

N=49		 P
Recipients at Cornell n (%) 43 (84.3%) 44 (89.8%) 0.60
Recipients at Outside Transplant Centers n (%) 8 (15.7%) 5 (10.2%)
Delayed Graft Function (yes), n (%) 5 (9.8%) 0 (0%) 0.057
Ureteral Complications* (yes), n (%) 1 (2.3%) 2 (4.5%) 1.0
Serum Creatinine (mg/dL), mean (SD)
1 month 1.4 ± 1.0 1.4 ± 0.5 0.71
6 months 1.3 ± 0.3 1.4 ± 0.5 0.32
12 months 1.2 ± 0.3 1.3 ± 0.5 0.23
Follow-Up (months), mean (SD) 18.3 ± 5.3 18.6 ± 5.6 0.82
Patient Survival, n (%) 50 (98.0%) 48 (98.0%) 1.0
Graft Survival, n (%) 50 (98.0%) 48 (98.0%) 1.0
*

Data available for Cornell recipients only